Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-13

Clinical Trial Update: Role of Altered Intestinal Permeability and Lipopolysaccharide in Thrombotic Risk and Vascular Injury in IBD Patients [NA]

View source ↗

Summary

This clinical trial update investigates whether altered intestinal permeability and exposure to lipopolysaccharide affect thrombotic risk and vascular injury in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: IBD | NA | Status: NOT_YET_RECRUITING